Cyclopharm Limited (AU:CYC) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cyclopharm Limited has announced that shareholders have passed all proposed resolutions at its recent Annual General Meeting, including the approval for a share buy-back, election of a new director, and adoption of a Loan Share Plan. While the share buy-back option has been approved, the company’s directors have no intention of executing this within the next 12 months. The company emphasized unanimous shareholder support with each resolution carried by an overwhelming majority.
For further insights into AU:CYC stock, check out TipRanks’ Stock Analysis page.